Possibilities of using topical retinoids and azelaic acid in acne therapy

封面

如何引用文章

全文:

详细

Background. Acne is a common, complex and multifactorial inflammatory disease that results from a variety of causes. Acne therapy is an urgent problem of dermatocosmetology. The clinical manifestations of dermatosis can be alleviated, and its long-term consequences can be prevented by early diagnosis and timely initiation of treatment, affecting multifaceted all parts of the pathogenesis.

Aims. To evaluate the clinical efficacy and safety of the use of monotherapy of 0.1% adapalene cream (Adaclean) with combined external therapy of 0.1% adapalene cream (Adaclean) with 20% azelaic acid cream (Azix-Derm) in the treatment of mild to moderate acne.

Methods. Under our supervision at the Department of Plastic Reconstructive Surgery, Cosmetology and Regenerative Medicine of the State Budgetary Educational Institution of Higher Professional Education Rost of the State Medical University of the Ministry of Health of Russia, the clinics “Ekaterininskaya” and “MIR-O-MED” there were 50 patients aged 12 to 50 years (18 (36%) men and 32 (64%) women) with mild and moderate acne. Patients with comedonal acne, in the absence of multiple inflammatory elements, which made up group 1 of observation (n = 16), were prescribed Adaclean cream, 1 time per day (evening) against the background of skin care. In the group with mild to moderate papulo-pustular acne and post-inflammatory changes (group 2, n = 34), patients were prescribed a combination of 0.1% adapalene cream and 20% azelaic acid cream (Adaclean (evening) and Azix-Derm (morning)). The follow-up period was 6 months.

Results. Total clinical remission after 6 months therapy was achieved in 70% of cases, a significant improvement — in 28%, improvement — in 2%. In patients with a comedonal form of acne against the background of monotherapy with Adaclean cream, clinical recovery was obtained in 44% of patients, a significant improvement — in 50%, and an improvement — in 6%. In patients from the group of papulo-pustular acne of mild to moderate severity, after 3 months the use of complex therapy Adaclean and Azix-Derm noted almost complete relief of the inflammatory process; after 6 months therapy clinical recovery was recorded in 58%, significant improvement — in 36%; 6% showed partial improvement, which is associated with irregular use of drugs and skin care products. After 6 months combined treatment was able to achieve regression of dyschromia in 18–46% of patients, atrophic scars — in 5–22%, which significantly improved the results of therapy and made it possible to achieve a good cosmetic effect.

Conclusion. The combined use of drugs for external use of adapalene (Adaclean) and AK (Azix-Derm) in the treatment of papulo-pustular acne of mild and AK (Azix-Derm) in the treatment of papulo-pustular acne of mild and moderate severity can significantly increase the effectiveness of treatment, achieve a stable clinical effect and remission of the disease, as well as improve the quality of life of patients.

作者简介

Olga Katkhanova

Rostov State Medical University

编辑信件的主要联系方式.
Email: okathanova@mail.ru
ORCID iD: 0000-0002-4537-401X

MD, Dr. Sci. (Med.), Professor

俄罗斯联邦, Rostov-on-Don

Galina Burtseva

Research Center “Dermatology Clinic”

Email: dermclinic@mail.ru

MD, Cand. Sci. (Med.)

俄罗斯联邦, Moscow

Anastasia Solovyova

Kuban State Medical University

Email: ssolovav@mail.ru
ORCID iD: 0000-0001-6443-1473

Student

俄罗斯联邦, Krasnodar

参考

  1. Eichenfield DZ, Sprague J, Eichenfield LF. Management of Acne Vulgaris: A Review. JAMA. 2021;326(20):2055–2067. doi: 10.1001/jama.2021.17633
  2. Tan JKL, Stein Gold LF, Alexis AF, Harper JC. Current Concepts in Acne Pathogenesis: Pathways to Inflammation. Semin Cutan Med Surg. 2018;37(3S):60–62. doi: 10.12788/j.sder.2018.024
  3. Harper JC. Acne vulgaris: What’s new in our 40th year. J Am Acad Dermatol. 2020;82(2):526–527. doi: 10.1016/j.jaad.2019.01.092
  4. Катханова О.А., Катханов А.М. Акне с позиции дерматолога и косметолога. Вестник дерматологии и венерологии. 2014;90(4):75–82. [Katkhanova OA, Katkhanov AM. Acne from the point of view of dermatologists and cosmetologists. Vestnik Dermatologii i Venerologii. 2014;90(4):75–82. (In Russ.)] doi: 10.25208/0042-4609-2014-90-4-75-82
  5. Dréno B, Bettoli V, Araviiskaia E, Sanchez Viera M, Bouloc A. The influence of exposome on acne. J Eur Acad Dermatol Venerol. 2018;32(5):812–819. doi: 10.1111/jdv.14820
  6. Carmina E, Dreno B, Lucky WA, Agak WG, Dokras A, Kim JJ, et al. Female Adult Acne and Androgen Excess: A Report from the Multidisciplinary Androgen Excess and PCOS Committee. J Endocr Soc. 2022;6(3):bvac003. doi: 10.1210/jendso/bvac003
  7. Samuels DV, Rosenthal R, Lin R, Chaudhari S, Natsuaki MN. Acne vulgaris and risk of depression and anxiety: A meta-analytic review. J Am Acad Dermatol. 2020;83(2):532–541. doi: 10.1016/j.jaad.2020.02.040
  8. Алиев А.Ш., Мухамедов Б.И., Колдарова Э.В., Ташкенбаева У.А. Сравнение методов оценки степени тяжести акне. Вестник дерматологии и венерологии. 2022;98(3):61–69. [Aliyev AS, Mukhamedov BI, Koldarova EV, Tashkenbaeva UA. Comparison of methods for assessing acne severity. Vestnik Dermatologii i Venerologii. 2022;98(3):61–69. (In Russ.)] doi: 10.25208/vdv1311
  9. Alsulaimani H, Kokandi A, Khawandanh S, Hamad R. Severity of acne vulgaris: comparison of two assessment methods. Clin Cosmet Investig Dermatol. 2020;13:711–716. doi: 10.2147/ccid.s266320
  10. Baldwin H, Webster G, Stein Gold L, Callender V, Cook-Bolden FE, Guenin E. 50 Years of Topical Retinoids for Acne: Evolution of Treatment. Am J Clin Dermatol. 2021;22(3):315–327. doi: 10.1007/s40257-021-00594-8
  11. Катханова О.А., Григорянц С.А., Глазко И.И. Тандем изотретиноина и геля Контрактубекс Анти-Ред в терапии акне. Российский журнал кожных и венерических болезней. 2021;24(3):285–296. [Katkhanova OA, Grigoryants SA, Glazko II. Combination of isotretinoin and Contractubex Anti-Red in acne therapy. Russian Journal of Skin and Venereal Diseases. 2021;24(3):285–296. (In Russ.)] doi: 10.17816/dv64197
  12. Духанин А.С. Современные критерии рациональной фармакотерапии акне у женщин. Взгляд клинического фармаколога. Клиническая дерматология и венерология. 2012;10(2):108–117. [Dukhanin AS. The current criteria for rational pharmacotherapy of acne in women. The viewpoint of a clinical pharmacologist. Klinicheskaya Dermatologiya i Venerologiya. 2012;10(2):108–117. (In Russ.)]
  13. Callender DV, Baldwin H, Cook-Bolden FE, Alexis AF, Stein Gold L, Guenin E. Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice. Am J Clin Dermatol. 2022;23(1):69–81. doi: 10.1007/s40257-021-00643-2
  14. Катханова О.А., Катханов А.М. Опыт использования топических ретиноидов и азелаиновой кислоты в терапии акне. Клиническая дерматология и венерология. 2015;14(6):120–125. [Katkhanova OA, Katkhanov AM. The experience in the use of topical retinoids and azelaic acid in therapy of acne. Klinicheskaya Dermatologiya i Venerologiya. 2015;14(6):120–125. (In Russ.)] doi: 10.17116/klinderma2015146120-125
  15. Kaufman BP, Aman T, Alexis AF. Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis and treatment. Am J Clin Dermatol. 2018;19(4):489–503. doi: 10.1007/s40257-017-0333-6
  16. Tan J, Alexis A, Baldwin H, Beissert S, Bettoli V, Del Rosso J, Dréno B, et al. The Personalised Acne Care Pathway-Recommendations to guide longitudinal management from the Personalising Acne: Consensus of Experts. JAAD Int. 2021;5:101–111. doi: 10.1016/j.jdin.2021.09.006
  17. Круглова Л.С., Иконникова Е.В. Результаты открытого сравнительного исследования эффективности и переносимости терапии двумя лекарственными формами адапалена (0,1% крем и 0,1% гель) с применением косметических средств и без них при акне легкой и средней степени. Клиническая дерматология и венерология. 2018;17(5):74–82. [Kruglova LS, Ikonnikova EV. The results of the open comparative study of the efficacy and tolerability of therapy with two dosage forms of adapalene (0.1% cream and 0.1% gel) as a monotherapy and in combination with cosmetic products in treatment of mild to moderate acne. Klinicheskaya Dermatologiya i Venerologiya. 2018;17(5):74–82. (In Russ.)] doi: 10.17116/klinderma20181705174
  18. Webster G. Combination azelaic acid therapy for acne vulgaris. A Am Acad Dermatol. 2000;43(2Pt3):S47–50. doi: 10.1067/mjd.2000.108318
  19. Schulte BC, Wu W, Rosen T. Azelaic acid: evidence-based update on mechanism of action and clinical application. J Drugs Dermatol. 2015;14(9):964–968.
  20. Кунгуров Н.В., Зильберберг Н.В., Кохан М.М., Полищук А.И. Потенциал разработки топических препаратов азелаиновой кислоты для терапии больных акне. Международный журнал прикладных и фундаментальных исследований. 2015;2(1):50–53. [Kungurov NV, Zilberberg NV, Kokhan MM, Polishchuk AI. Potential of azelaic acid in topical medications for the treatment of acne patients. Mezhdunarodnyj zhurnal prikladnyh i fundamental’nyh issledovanij. 2015;2(1):50–53. (In Russ.)]
  21. Снарская Е.С. Роль и место азелаиновой кислоты в маршрутах пациентов с вульгарным акне. Вестник дерматологии и венерологии. 2020;96(5):65–70. [Snarskaya ES. The role and place of azelaic acid in the routes of patients with acne vulgaris. Vestnik Dermatologii i Venerologii. 2020;96(5):65–70. (In Russ.)]. doi: 10.25208/vdv1175-2020-96-5-65-70
  22. Moore D.E. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf. 2002;25(5):345–372. doi: 10.2165/00002018-200225050-00004
  23. Gould JW, Mercurio MG, Elmets CA. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol. 1995;33(4):551–573. doi: 10.1016/0190-9622(95)91271-1
  24. Jeanmougin M, Pedreiro J, Bouchet J, Civatte J. Phototoxic activity of 5% benzoyl peroxide in man. Use of a new methodology. Dermatologica. 1983;167(1):19–23.
  25. Белякова М.М., Бессонов С.И., Сергеев Б.М., Смирнова Е.Н., Добров Е.Н., Копылов А.М. Скорость фотолиза тетрациклина при облучении светом с длиной волны 365 нм. Биохимия. 2003;68(2):182–187. [Beliakova MM, Bessonov SI, Sergeyev BM, Smirnova EN, Dobrov EN, Kopylov AM. Rate of tetracycline photolysis under irradiation with 365 nm light. Biochemistry (Mosc). 2003;68(2):182–187. (In Russ.)] doi: 10.1023/a:1022697312042
  26. Ortonne JP. Depigmenting chemical agents. Ann Dermatol Venereol. 1986;113(8):733–736.
  27. Graupe K, Cunliffe WJ, Gollnick HP, Zaumseil RP. Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. Cutis. 1996;57(1 Suppl):20–35.
  28. Thiboutot D. Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. J Drugs Dermatol. 2008;7(1):13–16.
  29. Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol. 2011;10(6):586–590.

补充文件

附件文件
动作
1. JATS XML
下载
2. Fig. 1. Forms of topical retinoids for acne treatment

下载 (354KB)
索引源数据
3. Fig. 2. Comparison of the absorption spectrum of various agents used for external acne therapy

下载 (1MB)
索引源数据
4. Fig. 3. Dynamics of the clinical picture in the combination therapy group of Adaclean and Azix-Derm

下载 (417KB)
索引源数据
5. Fig. 4. Evaluation of the clinical efficacy of treatment according to the IGA scale

下载 (204KB)
索引源数据
6. Fig. 5. Dynamics of the DIA index in the comparison groups before and after treatment

下载 (429KB)
索引源数据
7. Fig. 6. The overall effectiveness of therapy in two groups, %

下载 (153KB)
索引源数据

版权所有 © Katkhanova O.A., Burtseva G.N., Solovyova A.V., 2024

Creative Commons License
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。
##common.cookie##